Advertisement
Screener

PANDION THERAPEUTICS, INC. Patents: Active

PANDION THERAPEUTICS, INC. Active Patents

4 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2018-11-28: Application 16203018; Invention IL-2 MUTEINS AND USES THEREOF; Applicant PANDION THERAPEUTICS, INC.; Status Patented Case.
  • 2018-08-23: Application 16109897; Invention IL-2 MUTEINS; Applicant Pandion Therapeutics, Inc.; Status Patented Case.
  • 2018-08-23: Application 16109875; Invention IL-2 MUTEINS; Applicant Pandion Therapeutics, Inc.; Status Patented Case.
  • 2018-05-24: Application 15988311; Invention Targeted Immunotolerance; Applicant Pandion Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2018-11-2816203018IL-2 MUTEINS AND USES THEREOFPANDION THERAPEUTICS, INC.Patented Case2021-03-1610946068US20190321446A1
Nathan HIGGINSON-SCOTT
Joanne L. VINEY
Jyothsna VISWESWARAIAH
Erik Robert SAMPSON
Kevin Lewis OTIPOBY
United States
United States
United States
United States
United States
MERTZ, PREMA MARIA
2018-08-2316109897IL-2 MUTEINSPandion Therapeutics, Inc.Patented Case2019-01-0810174092
Nathan Higginson-Scott
Joanne L. Viney
Jyothsna Visweswaraiah
Erik Robert Sampson
Kevin Lewis Otipoby
United States
United States
India
United States
United States
MERTZ, PREMA MARIA
2018-08-2316109875IL-2 MUTEINSPandion Therapeutics, Inc.Patented Case2019-01-0810174091
Nathan Higginson-Scott
Joanne L. Viney
Jyothsna Visweswaraiah
Erik Robert Sampson
Kevin Lewis Otipoby
United States
United States
India
United States
United States
MERTZ, PREMA MARIA
2018-05-2415988311Targeted ImmunotolerancePandion Therapeutics, Inc.Patented Case2020-06-0910676516US20180340014A1
Joanne L. Viney
Nathan Higginson-Scott
United States
United States
MERTZ, PREMA MARIA